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a  b  s  t  r  a  c  t
The  hepatitis  C virus  (HCV)  genome  encodes  a 63  amino  acid  (aa)  protein,  p7, which  is  located  between
the  structural  and  non-structural  proteins.  p7 localizes  to endoplasmic  reticulum  membranes  and  is com-
posed  of  two  transmembrane  domains  (TM1  and  TM2)  and  a cytoplasmic  loop.  While its exact  role  is
unknown,  p7  is  crucial  for assembly  and/or  release  of  infectious  virus  production  in cell culture,  as  well
as infectivity  in  chimpanzees.  The  contribution  of p7  to  the  HCV  life cycle  may  result from  at  least  two
distinct  roles.  Firstly,  several  studies  have  shown  that  p7  acts  as an  ion  channel,  the  functionality  of  which
is  critical  for  infection.  Secondly,  p7 interacts  with  NS2  in a manner  that  may  regulate  the  targeting  of
other  structural  proteins  during  the  assembly  process.  In this  study,  we  observed  that  mutations  in  TM1
and the cytoplasmic  loop  of  p7 decreased  infectious  virus  production  in  a  single-cycle  virus  production
assay.  Analysis  of  intra-  and  extracellular  virus  titers indicated  that p7  functions  at a stage  prior  to gen-
eration  of  infectious  particles.  These  effects  were  not due  to altered  RNA  replication  since  no  effects  on
levels  of  NS3  or NS5A  protein  were  observed,  and  were  not  a  consequence  of  altered  recruitment  of  core
protein  to  lipid  droplets.  Similarly,  these  mutations  seemingly  did  not  prevent  nucleocapsid  oligome-
rization.  Importantly,  we found  that an  alanine  triplet  substitution  including  the  two  basic  residues  of
the  cytoplasmic  loop,  which  is integral  to p7 ion  channel  function,  signiﬁcantly  reduced  E2 glycopro-
tein  levels.  A time  course  experiment  tracking  E2  levels  indicated  that  E2  was degraded  over  time,  as
opposed  to  being  synthesized  in reduced  quantities.  The  results  of  this  study  provide  strong  evidence
that  one  of the functions  of  p7 is  to protect  HCV  glycoproteins  from  premature  degradation  during  virion
morphogenesis.
 201©
. Introduction
Hepatitis C virus (HCV) infection is a major global health prob-
em with an estimated 123–180 million people infected worldwide,
hich represents 2–3% of the global population (Shepard et al.,
005; Martins et al., 2011). HCV infection frequently causes chronic
iver disease that can progress to cirrhosis and hepatocellular car-
inoma. Prior to the recent introduction of direct-acting antivirals
n clinics, treated individuals received a combination of pegylated
nterferon and ribavirin, which is poorly effective and associated
ith severe side effects (Michaels and Nelson, 2010). Therefore,
n alternative therapeutic strategy composed of a multi-targeted,
irus-speciﬁc approach is required. To realize this potential we
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must ﬁrst gain a better understanding of the basic function of some
of the more poorly understood viral proteins.
HCV is a small enveloped virus that belongs to the Hepacivirus
genus within the Flaviviridae family. The viral genome is a single-
stranded, positive sense RNA molecule of approximately 9.6 kb
in length, and encodes approximately 3000 amino acids (aa)
(Tellinghuisen et al., 2007; Murray et al., 2008). The viral polypep-
tide chain is generated following recognition of the viral RNA
genome by host cell translation machinery, and is co- and post-
translationally processed by host and viral proteases to liberate
individual viral gene products (Bartenschlager et al., 2011). The
N-terminal region of the generated polyprotein encodes three pro-
teins, namely core and the envelope proteins E1 and E2, which
provide structural components of the virus particle (Op De Beeck
et al., 2004; McLauchlan, 2009). The C-terminal portion encodes the
viral non-structural proteins, including NS3, NS4A, NS4B, NS5A, and
NS5B, which are all essential for production of viral RNA, and many
Open access under CC BY-NC-ND license.of these proteins also play roles in virus assembly (Moradpour et al.,
2007; Appel et al., 2008; Ma  et al., 2008; Masaki et al., 2008; Jones
et al., 2009, 2011; Popescu et al., 2011a,b). The HCV polyprotein also
encodes two  additional proteins, known as p7 and NS2, that are not
icense.
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Fig. 1. Construction of p7 mutants. Seven alanine triplet mutants were constructed in the background of JFH1D, which exhibits enhanced infectious virus production
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cid  compositions are shown, with mutated residues in bold and underlined, and af
riginal  amino acid was alanine.
nvolved in viral RNA replication, but are believed to be involved in
iral assembly and/or release (Jones et al., 2007; Steinmann et al.,
007; Jirasko et al., 2008, 2010; Popescu et al., 2011a,b; Stapleford
nd Lindenbach, 2011; de la Fuente et al., 2013).
The viral protein p7 was ﬁrst identiﬁed by expression of a series
f C-terminally truncated HCV polyproteins fused to a human c-
yc  epitope tag, which mapped it between E2 and NS2 (Lin et al.,
994). HCV p7 is a 63aa protein that localizes to the ER and contains
wo transmembrane domains (TM1 and TM2) connected by a short
ytoplasmic loop with both the amino- and carboxy-termini ori-
nted toward the lumen (Carrere-Kremer et al., 2002). The only
unctional study of p7 in vivo indicated that p7 is essential for
uccessful intrahepatic infection in the chimpanzee model and
llustrated its critical role in the viral life cycle (Sakai et al., 2003).
urthermore, p7 was shown to homo-oligomerize and possess ion
hannel activity in artiﬁcial lipid bilayers in vitro (Grifﬁn et al., 2003;
avlovic et al., 2003; Grifﬁn et al., 2004; Luik et al., 2009). This activ-
ty has led to the inclusion of p7 into a group of proteins called
iroporins, such as M2  of inﬂuenza virus and Vpu of HIV-1, which
re capable of modulating membrane permeability in order to assist
n viral entry, assembly or release (Wang et al., 2011). The ion chan-
el activity of p7 is sensitive to multiple ion channel inhibitors such
s amantadine and rimantadine in a genotype-dependent manner
Grifﬁn et al., 2008). However, only amantadine in combination
ith pegylated interferon and ribavirin has been studied in clin-
cal trials, but showed limited efﬁcacy with inconclusive antiviral
ctivity (Castelain et al., 2007).
While it is known that p7 is important for the production
f infectious virus, there is some debate as to the exact step at
hich p7 acts. For example, some studies employing full-length
CV chimeras have indicated that p7 acts at a late stage dur-
ng viral assembly and release (Steinmann et al., 2007; Yi et al.,
007), whereas other work indicated that p7 functions at an early
tage during virion morphogenesis (Jones et al., 2007). It has also
een shown that p7 interacts with NS2 and that this interaction
s required for efﬁcient viral assembly and release (Jirasko et al.,
010; Boson et al., 2011; Ma  et al., 2011; Popescu et al., 2011a,b;
ieyres et al., 2013). In addition, a comprehensive study that aimed
o characterize the contribution of p7 to organelle pH regula-
ion and virus production showed that during HCV infection, p7
ould equilibrate intracellular vesicle pH and reduce the number
f highly acidic vesicles more rapidly than ion channel defective
7 mutant sequences. This study also showed that H+ conduc-
ance was sensitive to viroporin inhibitors (Wozniak et al., 2010).
hese results indicate that exposure to acidic pH renders HCV
articles non-infectious. However, exactly how this pH-regulating012R), (indicated by *). The p7 TM1, TM2 and the cytoplasmic loop with the amino
 polyprotein aa numbers on the right. Valine was  introduced at positions where the
function of p7 affects the virus itself remains an important
question.
The aim of this study was to further elucidate the role of p7 in the
HCV life cycle through the use of a highly adapted version of JFH-1
containing previously described adaptive mutations (Russell et al.,
2008). We have performed an extensive mutagenesis analysis of p7
by creating multiple alanine triplet mutations spanning TM1  and
the cytoplasmic loop. These mutant virus genomes were analyzed
for their effects on infectious virus production in both multiple-
and single-cycle virus production assays. Detailed functional char-
acterization of the effects of these mutations at multiple stages
of the HCV life cycle were then performed, including polyprotein
processing, core/lipid droplet association, core protein oligomeri-
zation and virus release.
2. Materials and methods
2.1. Cell culture
Transfections and infections were performed in Huh-7.5 cells
(generous gift from C.M. Rice, Rockefeller University/Apath Inc.
LLC, USA; Blight et al., 2002) and S29 cells (subclone of Huh-7
cells representing a single-cycle virus production assay (Russell
et al., 2008), generous gift from S. Emerson, NIH, USA). Both cell
lines were cultured in Dulbecco’s Modiﬁed eagle’s medium (DMEM,
Invitrogen) supplemented with 10% fetal calf serum and 1% peni-
cillin/streptomycin, referred to as complete medium. All cells were
grown at 37 ◦C in 5% CO2.
2.2. Cloning and plasmid construction
Plasmids were constructed in the backbone of JFH1D (adapted
genotype 2a genome; Fig. 1). PCR mutagenesis was  employed to
introduce the desired mutations (Fig. 1) with primers that included
the BsiWI  and NotI restriction sites within the JFH1D backbone.
The JFH1D plasmid and PCR products were digested with BsiW1
and Not1 (New England Biolabs) and fragments gel-puriﬁed then
ligated using the Rapid DNA Ligation Kit (Roche). The GDD  neg-
ative control was  created using the QuikChange II XL Site-Directed
Mutagenesis Kit (Agilent Technologies), using speciﬁc primers that
omitted the GDD motif of NS5B. The same strategy was  also
employed to create the JFH1A4S backbone using a primer encoding
the E1 A4 epitope in the backbone of JFH1S, which includes only
the NS2 adaptive mutation. The p7 mutations were then recreated
by substituting the BsiWI  and AleI digested fragment from the orig-
inal p7 mutant plasmids into JFH1A4S. All plasmid sequences were
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eriﬁed by enzymatic digestion and double-stranded DNA
equencing. All primer sequences and detailed information
egarding the cloning procedures are available upon request. Note
hat the adaptive mutations present within each construct (JFH1D,
FH1S and JFH1A4S) are described in Section 3 the ﬁrst time that
hey are mentioned.
.3. In vitro transcription and RNA transfection
Mutant and control plasmids were linearized by XbaI digestion
or 2 h at 37 ◦C and 1 g of each linearized plasmid was  used for
n vitro RNA transcription using the T7 Megascript kit (Ambion).
NA integrity was veriﬁed by gel electrophoresis. RNA transcripts
ere transfected using DMRIE-C reagent (Invitrogen) into 1 × 106
uh-7.5 or S29 cells plated in 10 cm cell culture dishes 24 h prior
o transfection.
.4. Antibodies
The following antibodies were used in this study: Mouse anti-
ore monoclonal antibody (mAb) (B2; Anogen) was  used for both
ndirect immunoﬂouresence at a dilution of 1:200 and Western
lotting analysis at a dilution of 1:1000; Mouse anti-NS3 mAb
t a dilution of 1:5000 (C65371M; Meridian Life Science); Mouse
Ab  A4 (anti-E1; a kind gift from Harry Greenberg, Stanford, USA;
ubuisson et al., 1994); Mouse anti-NS2 (6H6, a kind gift from
harles M.  Rice, Rockefeller University, USA; Dentzer et al., 2009)
oth used for Western blot analysis at dilutions of 1:2000; Mouse
nti-E2 (AP33; generous gift from Genentech, USA/Arvind Patel,
RC-University of Glasgow, UK; Clayton et al., 2002) used at a dilu-
ion of 1:1000; Mouse anti-GAPDH mAb  at a dilution of 1:10,000
Abcam); sheep anti-NS5A antiserum (a kind gift from Mark Harris,
niversity of Leeds, UK) used for Western blot analysis at dilu-
ions of 1:10,000. HCV core in gradient analyses was  detected using
ouse anti-core mAb  (MA1-080; Pierce Research) at a dilution
:1000, and mouse anti-ADRP (Progen Biotechnik) was used at a
ilution of 1:1000. Alexa Flour® 488 anti-mouse secondary anti-
ody (Invitrogen) was used for indirect immunoﬂourescence at
 dilution 1:1000. Goat anti-mouse and donkey anti-sheep HRP-
abeled secondary antibodies (Santa Cruz Biotechnology) were used
or Western blot analysis at a dilution of 1:1000.
.5. Indirect immunoﬂuorescence
Cells were grown on 8-well chamber slides (Thermo Scientiﬁc),
xed in 100% acetone for 2 min, washed with phosphate buffer
aline (PBS) and incubated with primary antibody for 20 min. Then,
lides were washed 3 times with PBS and incubated with the sec-
ndary antibody for an additional 20 min  and washed 3 times with
BS. Slides were then mounted with Vectashield Hard Set mounting
edium containing DAPI (Vector Laboratories).
.6. Virus titration
Virus titers were determined by endpoint dilution assay for
ocus-forming units (ffu) as described previously (Zhong et al.,
005). Brieﬂy, 8-well chamber slides were seeded with 4 × 105
uh-7.5 cells per well 24 h prior to infection. At 72 h post-
ransfection, cell supernatants were clariﬁed through Millex-HV
5 m ﬁlters (Millipore) before being serially diluted 10-fold with
omplete DMEM.  100 l of each dilution was inoculated for 4 h
efore being removed and replaced with complete DMEM.  At
2 h post-infection cells were ﬁxed and visualized by indirect
mmunoﬂuorescence for core protein. Virus titers were expressedrch 176 (2013) 199– 210 201
as the number of ffu per ml  of supernatant, where a focus was
deﬁned by a cluster of 3 or more infected cells.
2.7. Titration of intracellular infectious virus
At 72 h post-transfection, cells were trypsinized, pelleted by
centrifugation at 400 × g and re-suspended in 1 ml  of complete
DMEM.  The re-suspended cells were then lysed by 4 cycles of
freeze/thaw (3 min  freeze/3 min  thaw) in a dry ice/methanol bath
and pelleted by centrifugation at 1500 × g. Virus titers were deter-
mined as described above.
2.8. SDS-PAGE and Western blotting analysis
At indicated time-points post-transfection, cells were
trypsinized, pelleted by centrifugation at 400 × g and re-suspended
in 300 l of passive lysis buffer (Promega). Cellular debris was
pelleted by centrifugation after 30 min  incubation on ice. A fraction
of the cell lysates was  then loaded in a 1:1 ratio with 2× loading
dye for SDS-PAGE. To visualize extracellular core protein, at
72 h post-transfection 12 ml of transfection supernatant (pooled
from 2 × 10 cm dishes) was  passed through a 0.45 m ﬁlter and
subjected to ultracentrifugation at 80,000 × g for 4 h at 4 ◦C using
a Sorvall TH-614 rotor. Pellets were re-suspended in 20 l of 2×
loading dye and the full amount was subjected to SDS-PAGE and
Western blotting.
2.9. Confocal microscopy
At 72 h post-transfection, cells were seeded onto 8-well cham-
ber slides and 48 h later washed with PBS and ﬁxed with 4%
Paraformaldehyde for 20 min, then washed and permeabilized with
0.1% Triton X-100 for 15 min. Following this, cells were washed and
incubated with anti-core Ab at a 1:200 dilution in 5% BSA/PBS. Next,
cells were washed 3 times and incubated with anti-mouse Alexa
Fluor® 488. To visualize lipid droplets the HCS LipidTOX Deep Red
neutral lipid stain (Invitrogen) was added to Vectashield Hard Set
mounting medium containing DAPI (Vector Laboratories) at a 1:200
dilution then added to the slides and examined by laser scanning
confocal microscopy.
2.10. Iodixanol density gradient fractionation
Two  10 cm plates per construct were transfected as described
above and cells were trypsinized 72 h post-transfection, pelleted
by centrifugation and re-suspended in 0.5 ml  of lysis buffer (50 mM
Tris (pH = 7.5), 140 mM NaCl, 5 mM EDTA and 0.5% Triton-X100)
and incubated for 30 min  on ice then cleared by centrifugation.
The clariﬁed 0.5 ml  were loaded over 4.5 ml  of pre-formed 10–50%
iodixanol gradients (prepared using OptiPrep Density Gradient
Medium (Sigma) and Hank‘s Balanced Salt solution (Invtrogen)).
Samples were then ultracentrifuged at 100,000 × g for 16 h at 4 ◦C
using a Beckman SW55Ti rotor. Next, ten fractions (0.5 ml/fraction)
for each construct were collected from the top of each tube. 50 l
from each fraction was retained before the protein precipitation
process for measurement of density of each fraction using a refrac-
tometer (Fisher Scientiﬁc). Detailed protocols are available upon
request. Proteins were extracted from the remainder of each frac-
tion by methanol precipitation at −20 ◦C for 40 min, and then
pelleted by centrifugation. The resultant pellets were re-suspended
in 50 l of 2× loading buffer, boiled and then probed for core protein
by Western blot analysis.
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.11. Baﬁlomycin A1 and NH4Cl treatments
4 pM Baﬁlomycin A1 (dissolved in DMSO) and 12 mM NH4Cl
ere prepared and used to treat Huh-7.5 or S29 cells that had
eceived mutant or control RNA 48 h previously. These concentra-
ions were chosen after testing a range of 1–50 pM (Baﬁlomycin
1) and 6–50 mM (NH4Cl). Supernatants from harvested cells were
sed for titer determination or Western blot as outlined previously.
. Results
.1. Mutations within TM1  and the cytoplasmic loop reduce
nfectious virus production
Previous reports have identiﬁed adaptive and compensatory
utations within p7 that enhanced virus production (Zhong et al.,
006; Delgrange et al., 2007; Kaul et al., 2007; Yi et al., 2007; Di
iorgio et al., 2008; Russell et al., 2008). The cytoplasmic loop
egion contains highly conserved basic residues, K33 and R35,
nown to impact infectivity in chimpanzees, as well as in vitro ion
hannel activity and virus production in cell culture (Sakai et al.,
003; Grifﬁn et al., 2004; Jones et al., 2007; Steinmann et al., 2007).
ased on these ﬁndings we hypothesized that a comprehensive
utational analysis of TM1  and the cytoplasmic loop might provide
dditional insight into the function of this protein. Accordingly,
even alanine triplet mutations (termed p7(1)–p7(7)) were gen-
rated to cover the TM1  and cytoplasmic loop of p7 (Fig. 1). These
utations were constructed in the background of a full-length, cell
ulture-adapted strain of HCV JFH-1 termed JFH1D, which contains
wo adaptive mutations in E2 (N417S) and NS2 (Q1012R) that func-
ion cooperatively to increase infectious virus production (Russell
t al., 2008).
To test the effects of the generated mutations on infectious virus
roduction, we used a single-cycle virus production assay. Here,
he mutant RNA genomes were transfected into S29 cells, which
xpress very low levels of CD81, the major receptor for HCV entry
Russell et al., 2008). These cells permit RNA replication and virus
article production, yet do not support virus entry, allowing a com-
arison between mutants and their ability to generate infectious
rogeny without the confounding effects associated with multi-
le infectious cycles. Core, NS3 and NS5A Western blot analyses
erformed on transfected S29 cell lysates at 72 h post-transfection
howed similar band intensities among the mutants when com-
ared with JFH1D, indicating that transfection efﬁciencies were
omparable and protein expression/processing was not affected by
he mutations generated in p7 (Fig. 2A). These comparable protein
evels also exclude possible effects on RNA replication or genome
nstability that may  have been caused by the generated mutations.
he negative control (GDD) contains a deletion within the active
ite of the HCV NS5B polymerase, and therefore produced no core,
S3 or NS5A.
At 72 h post-transfection, S29 cells were trypsinized and
e-plated in 8-well chamber slides. Two days later indirect
mmunoﬂuorescence analysis conﬁrmed that all mutant genomes
nd the JFH1D control possessed relatively similar HCV core stain-
ng patterns, with approximately 25% of cells being positive for core
Fig. 2B). Cells transfected with GDD displayed no core-positive
ells.
Next, to quantify the effects of the generated mutations on
irus production, we measured the levels of infectious virus
resent in the supernatants of transfected cells (Fig. 2C). Muta-
ion p7(1), (located at the amino-terminal end of TM1) p7(4),
near the carboxy-terminal end), as well as mutations p7(6) and
7(7) (within the cytoplasmic loop) reduced infectious virus pro-
uction to levels lower than the detection limit of the assay. Inrch 176 (2013) 199– 210
contrast, p7(2) and p7(3), located in the central region of TM1,
decreased virus production by ∼2 logs. The mutation near the
carboxy-terminal end of TM1  (p7(5)) showed little effect on virus
production, which was  likely due to the conservative amino acid
changes comprising this mutation (VAA-AVV). Taken together,
these data indicated that TM1  and the cytoplasmic loop of p7 are
important for infectious virus production, and that the amino acids
located within the central region of TM1  are seemingly less critical
for p7 function.
To verify these ﬁndings, we repeated the above experiments in
Huh-7.5 cells and found that the levels of core, NS3 and NS5A pro-
teins on Western blots were apparently different among the mutant
viruses (Supporting Fig. 1A). Core immunoﬂuorescence staining
patterns were also different from that observed in S29 cells (Sup-
porting Fig. 1B), demonstrating that mutations p7(1), p7(4), p7(6)
and p7(7) substantially affected virus spread. Mutant virus p7(5)
exhibited similar core staining to that of JFH1D with >90% of the
cells positive for core. The GDD control displayed no core signal.
Virus production at 72 h post-transfection of Huh-7.5 (Supporting
Fig. 1C) was higher than that from S29 cells (Fig. 2C), but overall pat-
terns between mutants were similar (minor differences between
cell lines for p7(1) and p7(6) were disregarded since they fell under
the assay cut-off). The observed differences on protein levels, core
staining patterns and virus titers correlated with the effects of virus
spread and are therefore due to the ampliﬁcation and accumula-
tion of virus that occurs in the permissive Huh-7.5 cells, which is in
agreement with previous ﬁndings (Jones et al., 2011). These results
indicated that the generated mutant genomes are indeed defective
in infectious virus production.
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.virusres.2013.06.008
3.2. Analysis of intracellular and extracellular species of virus
particles
The reduction of extracellular infectious virus exhibited by
some of the p7 mutants could result from two  possibilities: (i)
p7 mutants exhibit wild-type levels of released virus particles,
but these have reduced infectivity, or (ii) an overall reduction in
the production of particles. To determine which of these possi-
bilities occurred in the case of our mutants, supernatants from
Huh-7.5 cells transfected with the mutants and controls were col-
lected at 72 h post-transfection, clariﬁed, layered over a 20% sucrose
cushion and subjected to ultracentrifugation. Huh-7.5 cells were
used in this case to maximize yields of virus. Western blot anal-
ysis was then performed on the pelleted material (Fig. 3A). Core
protein was  detectable only for genomes that produced signiﬁ-
cant levels of infectious particles (JFH1D and p7(5)), demonstrating
that the mutations introduced into p7 decreased the production of
core-containing particles, as opposed to reducing the infectivity of
secreted virions.
From the results outlined above, we next investigated whether
the p7 mutants that produced little or no extracellular infectivity
were also compromised for intracellular infectivity. Accordingly,
S29 cells transfected with p7 mutants and controls were subjected
to multiple freeze/thaw cycles to obtain intracellular infectious
virus at 72 h post-transfection. In parallel, ﬁltered supernatants
were collected and viruses from both sources were used to inoc-
ulate naïve Huh-7.5 cells to measure infectious titers (Fig. 3B).
All mutants with lowered extracellular titers also displayed sim-
ilar reductions in the levels of intracellular infectious virus. Taken
together, these results demonstrate that the mutations made
within p7 resulted in an absence of core-containing HCV particles
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Fig. 2. Single-cycle virus production assay analysis of p7 mutant viruses. (A) S29 cells transfected with the p7 mutants or controls (JFH1D and GDD) were lysed and probed
with  antibodies recognizing core, NS3, NS5A and GAPDH by Western blot analysis. (B) S29 cells were transfected with equivalent amounts of transcribed RNA representing
p7  mutants and controls (JFH1D and GDD). At 72 h post-transfection, cells were seeded onto 8-well chamber slides and two days later washed, ﬁxed and stained for core
(green)  and DAPI (blue). Scale bars represent 50 m.  (C) Culture supernatants were ﬁltered and serially diluted to infect naïve Huh-7.5 cells. At three days post-infection virus
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utside the cell, most likely resulting from their compromised abil-
ty to generate infectious particles in the intracellular environment.
.3. Mutations in p7 TM1  and the cytoplasmic loop do not affect
ore sedimentation proﬁles
The above data indicated that the selected p7 mutations within
M1  and the cytoplasmic loop are unable to produce intracellular
nfectious virions. However, it was unclear whether these mutants
ere assembling intracellular particles that were non-infectious,
r were incapable of building the nucleocapsid structure. Typi-
ally, density gradient fractionation of transfected cell lysates has
evealed that intracellular HCV core exists at various densities, pre-
umably representing sequential stages of capsid assembly. These
pecies are thought to include monomeric core associated with LD,
nd oligomerized core representing both newly-forming nucleo-
apsids and virions associated with triglycerides and -lipoprotein
VLDL and LDL) complexes (Andre et al., 2002; Gastaminza et al.,
006; Alsaleh et al., 2010; Jones et al., 2011). Therefore, we sought
o determine whether any of our p7 mutants displayed altered pat-
erns of core distribution following centrifugation through density
radients.
To do this, two mutations within TM1  (p7(2) and p7(4))
nd one mutation within the cytoplasmic loop (p7(7)) were
elected for gradient analysis because they spanned the TM1  and
ytoplasmic loop region of p7. Also, these mutants displayed a
pectrum of effects on virus production; (p7(2)) showed a mod-
rate reduction, whereas p7(4) and p7(7) produced no detectable
nfectious virus. These mutant RNA genomes were transfected intore performed in triplicate and error bars represent standard error of the mean. The
ive of three independent transfection/infection experiments. (For interpretation of
is article.)
Huh-7.5 cells, and 72 h later, intracellular lysates were harvested
using TNE buffer containing 0.5% Triton X-100. This mild deter-
gent was  chosen to preserve core-core oligomers within the lysate
while disrupting core-membrane complexes that may  otherwise
be sufﬁciently dense to traverse into the gradient and be misinter-
preted as multi-ordered structures. Lysates were then loaded over
10–50% iodixanol gradients and subjected to ultracentrifugation.
Ten gradient fractions were collected from top (fraction 1) to bot-
tom (fraction 10) and analyzed by Western blot for core (Fig. 4).
In all constructs tested, varying core protein levels were observed
in fractions 1–3, likely representing monomeric core species (den-
sities ranging from 1.019 to 1.090 g/cm3) (Fig. 4). The strongest
core bands, which we propose represent naked viral nucleocap-
sids, typically appeared in fractions 6 and 7 with a density range
of 1.145–1.169 g/cm3. It is unlikely that these core structures were
enveloped/complexed with membranes, since no infectivity was
associated with these (or any) fractions. While slight variations
were regularly observed in these assays, we did not observe any
consistently noticeable differences between JFH1D and any of the
p7 mutants tested with respect to core patterns on Western blots,
except that JFH1D showed higher core band intensities in the blots
due to its ability to spread and produce more infectious virus. How-
ever, using a lysis buffer containing a detergent capable of breaking
core-core interactions (TNE + 0.5% SDS) resulted in a loss of core
from fractions 6 and 7, with most of the protein now being found
in the top fractions of the gradient (Fig. 4).
It should be noted that a comparison of lysis methods (freeze-
thaw versuss TNE + 0.5% TX-100) on cells harboring JFH1D revealed
differences in core banding patterns, indicating that these distinct
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Fig. 3. Extracellualr particls production and comparison of intracellular vs. extracel-
lular infectious virus. (A) Huh-7.5 cells were transfected with equivalent amounts of
transcribed RNA representing p7 mutants and controls (JFH1D and GDD) for 72 h.
12  ml  of supernatants (pooled from two 10 cm dishes) representing p7 mutants and
controls were loaded over 2 ml of 20% sucrose, ultracentrifuged and the pellet probed
by Western blot for core protein. Results are representative of two independent
transfection/infection experiments. (B) S29 cells were transfected as above and 72 h
post-transfection extracellular (solid bars) and intracellular (open bars) infectious
v
p
t
l
i
n
p
v
t
t
1
2
c
c
n
p
t
c
s
c
f
2
3
t
r
p
H
s
u
Fig. 4. Iodixanol gradient analysis of p7 mutant viruses. Huh-7.5 cells were trans-
fected with RNA representing selected p7 mutant viruses including TM1 mutants
p7(2) and p7(4) as well as the cytoplasmic loop mutant p7(7), and JFH1D was used
as  a control. At 72 h post-transfection intracellular lysates were harvested, loaded
over preformed 10–50% iodixanol gradients and subjected to ultracentrifugation.
Ten fractions from each tube were collected from top (fraction 1) to bottom (frac-
tion 10) Density measurements (g/cm3) on each fraction were measured using airus production were measured by focus-forming assay in triplicate, and means
lus standard errors are plotted. Results are representative of two independent
ransfection/infection experiments.
ysis methods inﬂuence the migration of liberated core through
odixanol gradients (Supporting Fig. 2). However, we also observed
o differences between p7 mutants and JFH1D when lysates were
repared by freeze-thaw (data not shown). Similarly, spinning har-
ested intracellular particles through a sucrose cushion prior to
heir ultracentrifugation through an iodixanol gradient made lit-
le difference (with the exception of ﬁltering out core in fractions
–3) to those results obtained without a cushion (Supporting Fig.
). Of further note is that RNA could not be measured for core-
ontaining gradient fractions, since gradients run on a negative
ontrol (GDD) also gave a peak of RNA in these fractions (data
ot shown). This ﬁnal result suggests that gradient-derived RNA
atterns obtained from intracellular lysates are complicated by
he existence of input RNA delivered during the transfection pro-
ess. Overall, the data obtained from density gradient experiments
uggest that the p7 mutants tested here were competent for nucleo-
apsid assembly.
Supplementary data associated with this article can be
ound, in the online version, at http://dx.doi.org/10.1016/j.virusres.
013.06.008
.4. p7 TM1  and the cytoplasmic loop do not affect core targeting
o lipid droplets
We  next wished to determine whether p7 might inﬂuence the
ecruitment of core protein to lipid droplets (LDs), the proposed
latform for virion formation (Miyanari et al., 2007). Accordingly,
uh-7.5 cells were transfected with the mutant genomes and
tained for core protein and LDs 72 h later. Huh-7.5 cells were
sed in this experiment in order to maximize the number ofrefractometer (top panel), and Western blot analyses for core and ADRP were per-
formed (middle and bottom panels). Results are representative of three independent
transfection/infection experiments.
core-positive cells available for observation. As shown in (Fig. 5),
no differences in core/LD association were observed between the
JFH1D control and any of the p7 mutants tested. These data conclu-
sively demonstrate that neither p7 TM1  nor the cytoplasmic loop
affect the targeting of core protein to LDs, and that any reductions
observed in infectious virus production did not result from failed
loading of core onto the surface of LDs.
3.5. Mutation of the p7 cytoplasmic loop results in a
time-dependent reduction of E2 levels
It has previously been shown that p7 can regulate pH in intracel-
lular compartments (Wozniak et al., 2010), presumably to protect
the virus from acid-induced degradation during viral egress. How-
ever, p7 may  have an additional, separate function that involves
an interaction with NS2, and this interaction may be important for
localization of p7 with other viral proteins, including core and E2,
at the site of assembly (Jirasko et al., 2010; Boson et al., 2011; Ma
et al., 2011; Popescu et al., 2011a,b; Vieyres et al., 2013). There-
fore, it became essential to test some of our p7 mutants for an
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Fig. 5. Analysis of core/lipid droplet association. Huh-7.5 cells were transfected with equivalent amounts of transcribed RNA representing p7 mutants and controls (JFH1D
and GDD). At 72 h post-transfection, cells were seeded onto 8-well chamber slides and two  days later washed and stained as described above. Cells were visualized by
confocal microscopy under oil immersion. Scale bars represent 10 m.  Enlarged areas from the merged image are shown on the right. Blue represents DAPI-stained nuclei,
green  ﬂuorescence represents HCV core protein and red represents lipid droplet staining. Results are representative of three independent experiments. (For interpretation
of  the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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ffect on viral glycoproteins E1 and E2. To do this, we ﬁrst gen-
rated two new constructs–JFH1S and JFH1A4S. JFH1S is the same
s JFH1D, except that it lacks the N417S adaptive mutation in E2.
his construct had to be used for E2 analyses because N417S is
ocated within the epitope recognized by most antibodies that bind
FH-1 E2, thereby preventing detection. In turn, JFH1S was further
odiﬁed by substituting a short sequence of E1 for the analogous
equence from HCV strain H77, to produce JFH1A4S. This strategy,
eported elsewhere, renders E1 detectable by the E1 antibody A4
Stapleford and Lindenbach, 2011). The modiﬁcations required to
roduce both these new constructs did reduce virus production
y approximately 15-fold (JFH1S) and 70-fold (JFH1A4S) compared
o JFH1D (Supporting Fig. 3). However, virus production remained
ufﬁcient for analysis.
Supplementary data associated with this article can be
ound, in the online version, at http://dx.doi.org/10.1016/
.virusres.2013.06.008
To examine effects on both E1 and E2, we ﬁrst introduced
elected p7 mutations (1, 3, 4, 6 and 7) into the background of
FH1A4S. Upon transfection of Huh-7.5 cells with these p7 mutants,
estern blot analysis indicated that all mutants displayed insigniﬁ-
ant variations in core, NS2 and E1 protein levels (Fig. 6A). However,
his was not the case for p7(7) (cytoplasmic loop mutant contain-
ng substitutions in the two conserved basic residues), where a
ubstantial reduction in E2 was apparent. These results were con-
rmed in S29 cells (Fig. 6A). To analyze the reduction in E2 more
uantitatively, the Western blot band intensities for E2 were mea-
ured by densitometry relative to that of core expressed from each
utant. Additionally, NS2 levels were measured in this manner
Fig. 6B). This analysis conclusively demonstrated that E2 levels
xpressed from p7(7) were signiﬁcantly lower compared to JFH1A4S
nd the other p7 mutants, whereas NS2 levels remained unchanged
Fig. 6A and B). These results suggest that modiﬁcation of the diba-
ic residues within the p7 cytoplasmic loop leads to a reduction of
2 glycoprotein levels.
Previous reports have demonstrated that alteration of the p7
ytoplasmic loop can result in the detection of E2-p7-NS2 precur-
ors by Western blot (Steinmann et al., 2007). While we  did not
bserve this effect in Fig. 6A, E2 and NS2 blots were repeated using
DS-based Laemmli buffer in addition to our usual CHAPS-based
uffer (Supporting Fig. 4). Here, we also saw no evidence for pre-
ursors on either the E2 or NS2 blots. Therefore, we presume that
he observed phenotype for p7(7) resulted from direct effects on
he protein itself rather than a processing defect. To further inves-
igate the observed reduction of E2 in the p7(7) mutant, we  carried
ut a time course analysis of E2 levels at 24, 48, and 72 h post-
ransfection in S29 cells. Since S29 cells are non-permissive for
ntry, they represent a relatively synchronized state of viral protein
roduction upon transfection, which is ideally suited for this exper-
ment. Here, the JFH1S strain of virus was used since it produces
igher viral titers than JFH1A4S and detection of E1 was  not required
or this experiment. p7(1) was also included as an additional con-
rol since, like p7(7), it produces no infectious virus, yet generates
ear wild-type levels of E2. Lysates were prepared from each time-
oint and E2, core, and GAPDH levels were probed by Western blot
Fig. 6C). It was observed that at 24 h post-transfection the mutants
nd controls produced barely detectable levels of both E2 and core.
y contrast, at the 48 h time-point, only p7(1) and the JFH1SA4S
ontrol displayed comparable levels of core and E2, with a slightly
educed amount of E2 in the case of p7(7). However, E2 levels
xpressed from p7(7) were noticeably reduced by 72 h compared
o what they were at 48 h, as well as being diminished compared
o the other constructs tested.
Supplementary material related to this article found, in the
nline version, at http://dx.doi.org/10.1016/j.virusres.2013.06.008rch 176 (2013) 199– 210
Finally, we  attempted to rescue both infectious virus produc-
tion and E2 levels from p7(7) by treating transfected cells with (i)
Baﬁlomycin A1, to inhibit vesicular acidiﬁcation as performed by
others (Wozniak et al., 2010) and (ii) NH4Cl, a lysosomal inhibitor
(Supporting Fig. 5). However, we  observed no restoration of virus
production or E2 to levels seen with JFH1S. Taken together, these
results indicated that the mutations present in p7(7) appear to
result in lower levels of E2, which cannot be restored through the
inhibition of lysosome or vesicular acidiﬁcation.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.virusres.2013.06.008
4. Discussion
The functionality of the p7 protein is one of the more poorly
understood aspects of the HCV life cycle. p7 is important for both
successful HCV infection in chimpanzees as well as virus produc-
tion in cell culture, yet is seemingly dispensable for virus entry and
RNA replication (Sakai et al., 2003; Jones et al., 2007; Steinmann
et al., 2007; Brohm et al., 2009; Meshkat et al., 2009; Vieyres et al.,
2013). Multiple studies indicate that p7 forms ion channels in arti-
ﬁcial membranes, leading to its inclusion in the viroporin protein
family (Grifﬁn et al., 2003; Pavlovic et al., 2003; Premkumar et al.,
2004). Recently, amino acids required for the ion channel activ-
ity of p7 were also shown to be important for pH modulation of
intracellular vesicles in cell culture, and this activity was  impor-
tant for maintaining infectious virus production (Wozniak et al.,
2010). In this study, we performed an extensive mutational anal-
ysis to determine at which stage of the viral life cycle p7 acts.
Alanine triplet mutations spanning TM1  and the cytoplasmic loop
were generated and tested for their ability to produce virus, and
subsequently, other stages of the viral life cycle were probed. The
data indicated that regions of both the cytoplasmic loop and TM1
of p7 are important for virus production. p7 was not involved in
virus release as reductions in both intra- and extracellular infec-
tious virus were observed. Furthermore, mutating these regions of
p7 did not alter core localization to lipid droplets, and capsid assem-
bly was  seemingly unaffected. Most importantly, we observed that
alanine substitution of the two basic residues within the cytoplas-
mic  loop of p7 caused a reduction in the amount of E2 present in
transfected cells.
The cytoplasmic loop of p7 links the two  TM helices and harbors
a conserved dibasic motif, R33 and R35, which appear to be impor-
tant for the ion channel activity (Grifﬁn et al., 2004). The importance
of the cytoplasmic loop in virus production was  shown previously
in multiple studies employing the HCVcc system, and in vivo after
intrahepatic injection of chimpanzees (Sakai et al., 2003; Jones et al.,
2007; Steinmann et al., 2007). Most of these studies concentrated
on the cytoplasmic loop, especially the R33 and R35 residues, since
it was  previously shown that these residues were important for
p7 ion channel activity in artiﬁcial membrane assays (Grifﬁn et al.,
2004). In this study we performed a comprehensive, side-by-side
comparison of viruses containing mutations covering all of TM1
and the loop. We  observed that the p7(7) mutant, which included
the dibasic residues discussed above, and mutation p7(6), which is
situated at the junction of the cytoplasmic loop and the TM1  helix,
both terminated virus production. Moreover, a previous study cre-
ated a W30F mutation, within the region that was  also mutated
in our p7(6), and found it to be an important residue for p7 func-
tion and virus production (Steinmann et al., 2007). Therefore, we
have conﬁrmed the importance of the cytoplasmic loop structure
in virus production.The data herein also showed that residues within TM1  are
important for virus production, with the greatest effects observed
for mutations at both N- and C-terminal ends of TM1. This
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Fig. 6. Effects of p7 mutations on E2 levels. (A) Huh-7.5 and S29 cells were transfected with the indicated p7 mutants generated in the background of JFH1A4S along with
appropriate controls (JFH1A4S and GDD). At 72 h post-transfection, intracellular lysates were obtained and probed with antibodies against E1, E2, NS2, core, and GAPDH
by  Western blot. (B) Band intensity measurements for core and E2 where each mutant’s band intensity was calculated relative to JFH1A4S. (C) A time course of E2, core,
a  cells 
r
o
o
r
r
o
c
a
p
a
p
(
g
o
i
d
bnd  GAPDH expression by Western blot at 24, 48, and 72 h post-transfection of S29
epresentative of two independent experiments.
bservation suggests that the positioning of the N- and C-termini
f TM1  might be critical for anchoring the membrane-spanning
egion into the ER, and that mutation of this sequence may  dis-
upt this positioning, thereby inhibiting virus production. Mutation
f amino acids located near the N-terminal end of TM1  (p7(1))
aused a complete abrogation of virus production. This result is in
greement with a study showing that the H17 residue (H767 in the
olyprotein of JFH-1) within TM1  is important for virus production
nd is part of a HXXXW-like motif found in the inﬂuenza virus M2
rotein, which is the main functional element of the M2  channels
Meshkat et al., 2009). However, a separate study generated a sin-
le alanine substitution at residue N17 (N767 in the polyprotein
f J6) in the context of the J6/JFH-1 chimeric virus and found an
nsigniﬁcant effect on virus production (Jones et al., 2007). These
iscrepancies might be explained by the chimeric nature of the viral
ackbone used in the later study, or may  result from the triplefor the mutants p7(1) and p7(7) generated in the background of JFH1S. Results are
alanine mutation studied here more drastically disrupting the
M2-like motif. Interestingly, it has been previously reported that
an adaptive mutation in this region (N15D; N765D in the JFH-1
polyprotein) enhanced virus production by 10-fold itself, further
demonstrating the importance of these residues and suggesting
that a putative interaction with other viral proteins is mediated
by residues contained within the region mutated in p7(1) (Russell
et al., 2008). Mutations p7(2) and p7(3) lie within the central region
of TM1  and reduced virus production to approximately 50% of the
levels observed with JFH1D. The alanines substituted in this region
replace uncharged hydrophobic amino acids (GLLYFA) and we  pro-
pose therefore that these substitutions likely alter the optimal
structure of this segment, but not sufﬁciently enough to termi-
nate virion production. Others have also found this region to have
a minimal effect on virus production (Jones et al., 2007). The p7(4)
mutation completely abrogated virus production, indicating the
2  Resea
i
i
a
i
c
t
r
o
g
u
t
F
A
t
c
t
i
f
n
d
t
f
t
p
d
r
b
(
a
d
i
t
a
a
s
o
s

b
a
2
d
d
t
d
c
c
m
e
m
p
d
u
f
w
s
t
c
c
4
d
e
t08 A.M. Atoom et al. / Virus
mportance of one or more amino acids in this region. Interest-
ngly, another study identiﬁed a compensatory mutation (F26L)
t position F26 (also mutated in p7(4)) that rescued a mutation
n the core protein (Murray et al., 2007), suggesting that p7 and
ore may  work together through a direct interaction that has yet
o be demonstrated. Thus, the targeted p7(4) residues might dis-
upt such an interaction. These results highlight that the integrity
f both the N- and C-terminal regions of TM1  is important for the
eneration of infectious virus. It should also be noted that, as is
sually the case for alanine-scanning mutagenic analyses, some of
he constructed mutations were more conservative than others.
or example, it was unsurprising that p7(5) (mutation from VAA to
AV) exhibited no reduction in virus production, most likely since
he overall folding of p7 was largely unaltered due to the minor
hanges being introduced. This would not be the case for some of
he other mutants, in which more drastic mutations were made,
ncluding p7(6) (mutation from WHI  to AAA) and p7(7) (mutation
rom RGR to AAA). In the case of these latter mutants, we can-
ot exclude that virus production is abrogated due to p7 structural
eformities resulting from the drastic amino acid changes.
During the early stages in virus assembly, core protein trafﬁcs to
he surface of LDs and is proposed to serve as a platform for virion
ormation (Miyanari et al., 2007). Thus, we have tested our muta-
ion at this stage and conclusively demonstrated that none of the
7 mutants tested affected core protein accumulation around lipid
roplets. One recent study proposed that the core/LD association
esults from inefﬁcient virus assembly, and that efﬁciently assem-
ling viruses do not show signiﬁcant levels of core/LD association
Boson et al., 2011). However, this was not the case in this study
s the efﬁciently-assembling JFH1D, as well as all virus production-
efective mutants showed equivalent core/LD association.
The molecular details of HCV assembly are currently under
ntense investigation and are a matter of much debate. Following
he recruitment of core to LDs, HCV capsid presumably begins to
ssemble through oligomerization of core, forming virus particles
ssociated with one copy of the viral genome. This step pre-
umably involves the production of multiple structures including
ligomerized core representing both newly-forming nucleocap-
ids, and end-stage nucleocapsids associated with triglycerides and
-lipoprotein (VLDL and LDL). Evidence for this model is supported
y the observed pattern of core distribution within density gradient
nalyses (Andre et al., 2002; Gastaminza et al., 2006; Alsaleh et al.,
010; Jones et al., 2011). In order to determine whether p7 plays a
irect role in nucleocapsid assembly, we performed iodixanol gra-
ient analyses on a select panel of p7 mutant viruses from cells
hat were lysed with a detergent-containing buffer. Based on the
ata shown in Fig. 5, we would conclude that p7 does not affect
ore assembly because we were able to detect dense species of
ore protein in fractions 6–8 of the gradient. However, while this
anuscript was in revision an article was published by Gentzsch
t al. (2013) that showed viruses lacking part of p7, or containing
utations in the loop, displayed an increased proportion of incom-
letely assembled capsids. At this point we cannot reconcile these
ifferent ﬁndings other than to note that different protocols were
sed in these two studies. For example, Gentzsch et al. (2013) per-
ormed sucrose-based rate zonal centrifugation on their mutants,
hereas we used iodixanol equilibrium gradients. In subsequent
tudies we will be interested to determine whether we can iden-
ify nucleocapsid assembly defects in our mutants by rate zonal
entrifugation.
Finally, Wozniak et al. (2010) found that p7 modulates intra-
ellular proton conductance and increases lysosomal pH from
.5 to 6.0 during HCV infection in cell culture. This report also
emonstrated that the acidiﬁcation inhibitor baﬁlomycin A1 and
xpression of inﬂuenza virus M2  protein restored virus produc-
ion from a HCV genome mutated at the basic residues of the p7rch 176 (2013) 199– 210
cytoplasmic loop. Presumably, such a function would be important
in protecting newly-formed virions from premature degradation
at a late stage in virion production, speciﬁcally the envelope gly-
coproteins. We  now show that a mutation within the loop that
includes the same two  basic residues also affected E2 protein
expression and/or stability. It is logical to suspect that a lower
pH could inactivate E2 by prematurely triggering conformational
changes, but it is surprising that this would result in degradation
of the glycoprotein, as we have observed. At this point we can only
postulate that such a conformational change might either expose
protease-sensitive regions of the protein or disrupt the stabiliza-
tion provided by heterodimerization of E2 with E1. In any event,
this result is in agreement with recently published work showing
that a virus containing a defective p7 generated virions that were
proteinase K-sensitive due to the lack of a viral membrane enve-
lope. Baﬁlomycin A1 and MG132 did not restore virus production
in our case, and this could be due to the possibility of the triple ala-
nine substitution causing a complete abrogation of the ion channel
activity or p7 topology. However, it is still unclear why this effect
on E2 was only observed in the context of the cytoplasmic loop
mutation (p7(7)). It is possible that p7 plays a dual role in the late
viral assembly process, on one hand it could protect immature gly-
coproteins from degradation through an ion channel-like activity,
but then could mediate proper targeting of viral glycoproteins to
the assembly site. This potential dual role for p7 would explain the
observation that other mutants, such as p7(1), p7(4) and p7(6) dis-
played similar reductions in virus production as did p7(7), but had
no effect on E2 levels. This notion is supported by a study showing
that pseudoreversion in p7 within TM1  of p7 (N15D) combined with
a mutation at NS2 (G25R) restored virus infectivity and colocaliza-
tion of NS2 around LDs along with E2 and NS3 (Jirasko et al., 2010),
and these effects were not a consequence of p7 ion channel func-
tion (Tedbury et al., 2011). Also, Ma  et al. showed that p7 deletion
and mutations within the cytoplasmic loop affected the intracellu-
lar distribution of NS2 and E2 (Ma  et al., 2011). Similarly, Staplford
et al. found that NS2 interaction with other viral proteins was
dependent on p7 coexpression (Stapleford and Lindenbach, 2011).
Furthermore, Vieyres et al. recently constructed a functional HCV
genome with a HA-tagged p7 and found that p7 interacted with
NS2 and colocalized with E2 on the ER membrane (Vieyres et al.,
2013). Therefore, it seems that p7 function may  be two-fold: pro-
tection of virion-associated E2 from acid-induced degradation that
is mediated by the ion channel activity subsequent to nucleocapsid
formation and during envelopment. This function would have been
disrupted by the p7(7) mutation studied herein, while in the sec-
ond role, p7 is required for proper targeting of viral glycoproteins
through a putative interaction between p7 TM1  and NS2.
5. Conclusion
We  have demonstrated that p7 TM1  and the cytoplasmic loop
are important for infectious virus production in cell culture. Our
main ﬁnding is that disruption to the integrity of the conserved
dibasic motif within the cytoplasmic loop of p7 results in dimin-
ished levels of E2 glycoprotein. Taken together with observations
by other groups, we speculate that p7 acts at a point in the life
cycle that is after nucleocapsid formation, but before virus release.
In this way, we believe that p7 is important for viral envelopment,
in that it protects E2 from premature degradation through an ion
channel-like activity. Then, through a second function it is involved
in interactions with other proteins in order to support late stage,
post-nucleocapsid virus assembly. Further mutational studies cov-
ering the remainder of p7 and more extensive analysis of the E1 and
E2 glycoproteins are required to better understand the mechanism
of action of p7 and further emphasize its potential as a novel target
for drug development.
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